NEPH

Nephros, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 11/13/2017
Contact Info
  • 41 Grand Avenue
  • River Edge, NJ 07661

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0001196298
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Business Status Blank Check a/o
Incorporated In: DE, USA
Year of Inc. 1997
Employees 14 a/o Nov 01, 2017
Company Officers/Contacts
Daron Evans President, CEO
Andrew Astor CFO
Company Directors
Arthur Amron
Paul Mieyal
Malcom Persen
Moshe Pinto
Service Providers
Accounting/Auditing Firm
Moody, Famiglietti, & Andronico
1 Highwood Drive
Tewksbury, MA, 01876
United States

Legal Counsel
Fredrikson & Byron, P.A.
200 S. Sixth St.
Suite 4000
Minneapolis, MN, 55402
United States

Investor Relations Firm
PCG Advisory Group
535 Fifth Avenue
24th Floor
New York, NY, 10017
United States

NEPH Security Details
Share Structure
Market Value1 $25,992,664 a/o Dec 11, 2017
Authorized Shares 90,000,000 a/o Nov 09, 2017
Outstanding Shares 54,151,383 a/o Nov 09, 2017
-Restricted 32,881,776 a/o Nov 09, 2017
-Unrestricted 21,269,607 a/o Nov 09, 2017
Held at DTC 18,821,122 a/o Nov 09, 2017
Float 22,750,000 a/o Jun 01, 2017
Par Value 0.001
Transfer Agent(s)
VStock Transfer LLC
Shareholders
Shareholders of Record 64 a/o Mar 30, 2016
Short Selling Data
Short Interest 182,859 (0.71%)
Nov 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security